Natus reopens Seattle plant after FDA warning
This article was originally published in Clinica
Diagnostics specialist Natus Medical has resumed production and shipping at its Seattle, Washington manufacturing site after the site was shut down due to an FDA warning earlier this year. The company's Olympic Medical facility, which manufactures and distributes diagnostic technology for newborn care and sleep disorders, was subject to an FDA inspection in April 2007 and received a warning letter concerning "process deficiencies" in October. It was voluntarily closed on November 1 and remained inactive for nearly a month.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.